Form 4 for OPRX OptimizeRx Corp
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-13 · accession 0001213900-21-048251 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-15 | 2021-09-13 | OPRX | FEBBO WILLIAM J | CEO, Dir | G - Gift | — | -8,600 | 536.0K | -2% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-13 | G | D | 8,600 | — | 536,041 | D | — | — | (F1) Shares represent a charitable gift/donation to the National Philanthropic Trust/William and Vanessa Febbo. The Reporting Person is not a Trustee and has no pecuniary interest or investment discretion. (F2) Price is not applicable to acquisitions or dispositions resulting from bona fide gifts. |